Models of dendritic cell development correlate ontogeny with function

被引:14
作者
Anderson, David A., III [1 ]
Murphy, Kenneth M. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 143 | 2019年 / 143卷
关键词
TRANSCRIPTION FACTOR PU.1; LYMPH-NODES; T-CELLS; REGULATORY FACTOR-4; MYELOID PROGENITOR; NEGATIVE REGULATOR; SUBSET DEVELOPMENT; IMMUNE-RESPONSE; STEADY-STATE; FLT3; LIGAND;
D O I
10.1016/bs.ai.2019.09.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rapid advances have been made to uncover the mechanisms that regulate dendritic cell (DC) development, and in turn, how models of development can be employed to define dendritic cell function. Models of DC development have been used to define the unique functions of DC subsets during immune responses to distinct pathogens. More recently, models of DC function have expanded to include their homeostatic and inflammatory physiology, modes of communication with various innate and adaptive immune lineages, and specialized functions across different lymphoid organs. New models of DC development call for revisions of previously accepted paradigms with respect to the ontogeny of plasmacytoid DC (pDC) and classical DC (cDC) subsets. By far, development of the cDC1 subset is best understood, and models have now been developed that can separate deficiencies in development from deficiencies in function. Such models are lacking for pDCs and cDC2s, limiting the depth of our understanding of their unique and essential roles during immune responses. If novel immunotherapies aim to harness the functions of human DCs, understanding of DC development will be essential to develop models DC function. Here we review emerging models of DC development and function.
引用
收藏
页码:99 / 119
页数:21
相关论文
共 134 条
  • [1] A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
    Akashi, K
    Traver, D
    Miyamoto, T
    Weissman, IL
    [J]. NATURE, 2000, 404 (6774) : 193 - 197
  • [2] Essential role for ICSBP in the in vivo development of murine CD8α+ dendritic cells
    Aliberti, J
    Schulz, O
    Pennington, DJ
    Tsujimura, H
    Sousa, CRE
    Ozato, K
    Sher, A
    [J]. BLOOD, 2003, 101 (01) : 305 - 310
  • [3] Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
    Alloatti, Andres
    Rookhuizen, Derek C.
    Joannas, Leonel
    Carpier, Jean-Marie
    Iborra, Salvador
    Magalhaes, Joao G.
    Yatim, Nader
    Kozik, Patrycja
    Sancho, David
    Albert, Matthew L.
    Amigorena, Sebastian
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (08) : 2231 - 2241
  • [4] Development, Diversity, and Function of Dendritic Cells in Mouse and Human
    Anderson, David A., III
    Murphy, Kenneth M.
    Briseno, Carlos G.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (11):
  • [5] Revisiting the specificity of the MHC class II transactivator CIITA in classical murine dendritic cells in vivo
    Anderson, David A., III
    Grajales-Reyes, Gary E.
    Satpathy, Ansuman T.
    Vasquez Hueichucura, Carlos E.
    Murphy, Theresa L.
    Murphy, Kenneth M.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (08) : 1317 - 1323
  • [6] Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells
    Anderson, KL
    Perkin, H
    Surh, CD
    Venturini, S
    Maki, RA
    Torbett, BE
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (04) : 1855 - 1861
  • [7] Production of type I interferons: plasmacytoid dendritic cells and beyond
    Asselin-Paturel, C
    Trinchieri, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) : 461 - 465
  • [8] CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation
    Auffray, Cedric
    Fogg, Darin K.
    Narni-Mancinelli, Emilie
    Senechal, Brigitte
    Trouillet, Celine
    Saederup, Noah
    Leemput, Julia
    Bigot, Karine
    Campisi, Laura
    Abitbol, Marc
    Molina, Thierry
    Charo, Israel
    Hume, David A.
    Cumano, Ana
    Lauvau, Gregoire
    Geissmann, Frederic
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (03) : 595 - 606
  • [9] Bagadia P., 2019, ANN REV CELL DEV BIO, V35
  • [10] An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development
    Bagadia, Prachi
    Huang, Xiao
    Liu, Tian-Tian
    Durai, Vivek
    Grajales-Reyes, Gary E.
    Nitschke, Maximilian
    Modrusan, Zora
    Granja, Jeffrey M.
    Satpathy, Ansuman T.
    Briseno, Carlos G.
    Gargaro, Marco
    Iwata, Arifumi
    Kim, Sunkyung
    Chang, Howard Y.
    Shaw, Andrey S.
    Murphy, Theresa L.
    Murphy, Kenneth M.
    [J]. NATURE IMMUNOLOGY, 2019, 20 (09) : 1174 - +